Skip to content

Risk Factors and Therapies for Gastric Variceal Bleeding in Japan:retrospective study

Risk Factors and Therapies for Gastric Variceal Bleeding in Japan:retrospective study - RIFTGV-J:retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000000783
Enrollment
300
Registered
2007-09-01
Start date
2007-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric fundal varices without history of bleeding

Interventions

None listed

Sponsors

National Hospital Organization Head quarter
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with gastric fundal varices who were diagnosed via endoscopy in the National Hospital Organization Hospitals 2.No history of gastric variceal bleeding 3.For patients with HCC the Milan criteria were applied (a solitary nodule < or = 5 cm; or two or three nodules < or = 3 cm without vascular invasion or extrahepatic metastasis), and patients were to undergo potentially curative treatments

Exclusion criteria

Exclusion criteria: 1.Patients with advanced HCC who were unable to undergo curative treatment 2. Patients with a solitary HCC (more than 5cm in a diameter of the tumor) who received surgical treatment 3.Recurrent HCC 4.Portal vein thrombosis 6.Patients received prophylactic treatments of gastric varices (e.g., TIPS, endoscopic treatment, surgery, PSE or splenectomy) 7.Patients whom judged to be inadequate by the doctor

Design outcomes

Primary

MeasureTime frame
Gastric variceal bleeding

Countries

Japan

Contacts

Public ContactManabu Hayashi

National Hospital Organization Iwakuni Clinical Center Department of Clinical Research

chiken@iwakuni-nh.go.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026